This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: University Medical Center Hamburg-Eppendorf. Active years: 2020-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2024
Title: The Innovative Contributions of Kerstin Schütze
Introduction
Kerstin Schütze is a prominent inventor based in Hamburg, Germany. She has made significant contributions to the field of biomedical research, particularly in the development of antigen-binding polypeptides. With a total of two patents to her name, her work focuses on the diagnosis and treatment of diseases characterized by increased CD38 expression.
Latest Patents
Kerstin Schütze's latest patents include innovative polypeptides specifically designed to bind to CD38. These polypeptides are suitable for both diagnostic and therapeutic applications. The inventions also encompass conjugates and pharmaceutical compositions that include these polypeptides. Furthermore, her patents detail methods for detecting CD38 and/or CD38-expressing cells in biological samples. A process for the purification and concentration of CD38 and/or CD38-expressing cells using these antigen-binding polypeptides is also described.
Career Highlights
Kerstin Schütze is affiliated with the University Medical Center Hamburg-Eppendorf, where she continues her research and development efforts. Her work has garnered attention for its potential impact on medical diagnostics and treatments.
Collaborations
Throughout her career, Kerstin has collaborated with notable colleagues, including Friedrich Nolte and Peter Bannas. These partnerships have contributed to the advancement of her research and the successful development of her patented inventions.
Conclusion
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile